OCUP Company Profile and Key Details
Ocuphire Pharma, Inc.
OCUP Stock Price Chart
Stock Price Today
Ocuphire Pharma, Inc. (OCUP) stock declined over -12.03%, trading at $1.17 on NASDAQ, down from the previous close of $1.33. The stock opened at $1.33, fluctuating between $1.07 and $1.36 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical trial for dim light or night vision disturbances; and Phase 2b clinical trial for pharmacologically induced mydriasis, as well as that has completed Phase 2 VEGA-1 trial for presbyopia. The company also develops APX3330, a twice-a-day oral tablet to target pathways relevant to retinal and choroidal vascular diseases, such as diabetic retinopathy and diabetic macular edema; and APX2009 and APX2014 second generation preclinical product candidates and analogs of APX3330. Ocuphire Pharma, Inc. is headquartered in Farmington Hills, Michigan.
Company Information
| Employees | 14 |
| Beta | 0.31 |
| Sales or Revenue | $19.05M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Ocuphire Pharma, Inc. (NASDAQ: OCUP) stock price is $1.17 in the last trading session. During the trading session, OCUP stock reached the peak price of $1.36 while $1.07 was the lowest point it dropped to. The percentage change in OCUP stock occurred in the recent session was -12.03% while the dollar amount for the price change in OCUP stock was -$0.16.
The NASDAQ listed OCUP is part of Biotechnology industry that operates in the broader Healthcare sector. Ocuphire Pharma, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Bindu Manne
Head of Market Devel. & Commercialization
Mr. Erik Sims
Director & Corporation Controller
Mr. Richard J. Rodgers M.B.A.
Interim Chief Executive Officer, Interim Pres & Director
Dr. Mitchell Brigell Ph.D.
Head of Clinical Devel. & Strategy
Dr. Daniela C. Oniciu Ph.D.
Global Head of R&D, Chemistry and Product Devel.
Mr. Chris Ernst
Global Head of QA & Manufacturing
Ms. Mina Patel Sooch M.B.A., MBA
Founder, Treasurer & Director
Ms. Amy Zaremba Rabourn C.P.A., CPA, MAcc
Senior Vice President of Fin.
Mr. Ronil A Patel M.S.
Vice President of Bus. Devel. & Market Strategy
Mr. Bernhard Hoffmann M.B.A.
Senior Vice President of Corporation Devel. & Operations and Sec.
OCUP's closing price is 9.19% higher than its 52-week low of $1.07 where as its distance from 52-week high of $3.40 is -65.58%.
Number of OCUP employees currently stands at 14.
Official Website of OCUP is: https://www.ocuphire.com
OCUP could be contacted at phone 248 681 9815 and can also be accessed through its website. OCUP operates from 37000 Grand River Avenue, Farmington Hills, MI 48335, United States.
OCUP stock volume for the day was 675.97K shares. The average number of OCUP shares traded daily for last 3 months was 139.15K.
The market value of OCUP currently stands at $31.74M with its latest stock price at $1.17 and 27.13M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com